The use of MK-801, a novel sympathomimetic, in adults with attention deficit disorder, residual type.
D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D003986:Dibenzocycloheptenes / Q000627:therapeutic use*; D016291:Dizocilpine Maleate; D006801:Humans; D011569:Psychiatric Status Rating Scales
D000927:Anticonvulsants; D003986:Dibenzocycloheptenes; D016291:Dizocilpine Maleate